GHB is addictive, and physical dependence can develop quickly in people who use it multiple times per day. What makes GHB particularly dangerous is how rapidly the body comes to rely on it and how severe withdrawal can be, with symptoms starting within an hour of the last dose and sometimes requiring intensive care.
How GHB Creates Dependence
GHB works on two receptor systems in the brain. It binds strongly to its own dedicated receptors and also activates the same receptors that respond to GABA, the brain’s primary calming chemical. Through these pathways, GHB triggers a surge of dopamine in the brain’s reward circuit, specifically by removing the normal brakes on dopamine-producing neurons. The result is a flood of dopamine in areas responsible for pleasure and motivation, which is the same basic mechanism behind most addictive substances.
This dopamine surge reinforces repeated use. Over time, the brain adjusts to the constant presence of GHB by dialing down its own receptor activity. Animal studies show measurable reductions in GABA receptor density in multiple brain regions after chronic exposure. That downregulation is the foundation of tolerance: the same dose stops working, pushing users to take more or dose more frequently.
How Quickly Tolerance Builds
Tolerance to GHB’s sedative and sleep-inducing effects develops with regular use, though the exact timeline varies by person and pattern. People who use GHB recreationally often escalate from occasional doses to round-the-clock dosing, sometimes every two to three hours, to maintain its effects. This pattern of frequent redosing is what most commonly tips users from tolerance into full physical dependence.
One important and dangerous detail: tolerance does not develop equally across all of GHB’s effects. While the sedative effects fade with repeated use, the drug’s ability to suppress breathing does not appear to build tolerance at the same rate. Research in animals found no difference in respiratory depression between the first and fifth day of daily dosing, even as other effects diminished. This mismatch means that as people increase their dose to chase the high, the risk of a life-threatening overdose grows.
The good news is that tolerance appears to be reversible. In animal models, sensitivity to GHB returned to normal after two to three weeks without the drug.
The Pattern That Leads to Addiction
Not everyone who tries GHB becomes addicted. The critical risk factor is frequency. People who develop dependence typically report using multiple doses throughout the day and night, often setting alarms to redose every few hours. Daily users and those who combine GHB with other substances experience adverse effects far more often than occasional users.
People with a history of alcohol or stimulant dependence may be especially vulnerable. Because GHB acts on the same GABA receptor system affected by alcohol and cocaine, individuals whose brains are already adapted to those substances can develop GHB cravings and dependence more readily.
When GHB is used as a prescription medication for narcolepsy (sold as sodium oxybate), addiction is rare. Out of roughly 26,000 patients tracked worldwide between 2002 and 2008, only four cases met the clinical criteria for addiction, a rate of about 0.015%. Ten additional cases of misuse were identified, bringing the total misuse rate to 0.039%. The difference comes down to controlled dosing, medical supervision, and a restricted distribution system. These numbers don’t apply to recreational use, where doses are unregulated and frequency is self-determined.
What GHB Withdrawal Looks and Feels Like
GHB withdrawal is one of the more dangerous substance withdrawal syndromes. Symptoms can begin within one hour of the last dose and typically peak around 24 hours, though they can persist for up to three weeks. The speed of onset catches many users off guard.
In the first three days, the most intense physical symptoms include muscle aches, muscle twitches, a racing heart, abdominal cramps, sweating, chills, shivers, and goosebumps. These tend to ease after the initial phase. Other symptoms are more stubborn: tremors, shaking hands, insomnia, sleepiness, and restlessness often persist with little improvement over 11 days or more. Cravings and fatigue are present throughout.
Psychological symptoms can be equally difficult. Anxiety, agitation, and feeling gloomy are common. Some people experience visual hallucinations that actually worsen after the first day rather than improving. In severe cases, withdrawal can progress to delirium, psychosis, or seizures, though these outcomes are less common when withdrawal is medically managed.
The severity of withdrawal is a major reason GHB dependence is medically serious. Data from emergency departments in New South Wales, Australia, showed GHB-related presentations quadrupled between 2015 and 2024, reaching 101 per 100,000 unplanned visits. More than half of those patients were triaged at the highest urgency levels. Nearly one in five required a breathing tube, and a similar proportion needed intensive care admission.
How GHB Withdrawal Is Treated
Stopping GHB abruptly after heavy use is dangerous and should not be attempted without medical support. The standard approach uses a tapering dose of sedative medications to prevent seizures and delirium, similar to the protocol for severe alcohol withdrawal.
For people with severe dependence (typically those dosing more than three times per day), inpatient detoxification is recommended. Clinicians use high doses of sedatives that are gradually reduced over about seven days. For lighter dependence, outpatient management with lower doses over the same timeframe is sometimes possible.
A medication called baclofen, which activates the same GABA receptors as GHB, is increasingly used alongside sedatives during detox. Because it partially mimics GHB’s receptor activity without the same high or reinforcing effects, it can smooth out the withdrawal process. Case series have reported fewer transfers to intensive care when baclofen is added, and several patients have described it as helpful. British clinical guidelines now recommend it as a standard addition to withdrawal management.
Physical Dependence and Psychological Craving
GHB dependence involves both components. The physical side is obvious in the withdrawal syndrome: the tremors, sweating, and seizure risk are the body reacting to the sudden absence of a chemical it has adapted to. But the psychological side persists long after the physical symptoms resolve. Cravings are among the most consistently reported symptoms throughout detoxification, remaining high from the first day through at least day 11 of treatment.
This dual nature means that completing detox is only the first step. The dopamine-driven reward learning that GHB produces can drive relapse long after the body has physically recovered, particularly in environments or social contexts associated with prior use.